Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Alliance for Clinical Trials in Oncology"'
Autor:
American College of Surgeons Clinical Research Program, Alliance for Clinical Trials in Oncology, Heidi D. Nelson, Kelley K. Hunt
Presented by the American College of Surgeons and the Alliance for Clinical Trials in Oncology, the first comprehensive, evidence-based examination of cancer surgery techniques as standards distills the well-defined protocols and techniques that are
Autor:
Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad, Brian Wolpin, Robert Marsh, Spencer Behr, Qian Shi, Michael Chuong, Lawrence H. Schwartz, Wendy Frankel, Eric Collisson, Eugene J. Koay, JoLeen M. Hubbard, James L. Leenstra, Jeffrey Meyerhardt, Eileen O’Reilly, for the Alliance for Clinical Trials on Oncology
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for Clinical Trials in Onc
Externí odkaz:
https://doaj.org/article/309dcfbae6bc4c4bbb5d12861352a1a3
Autor:
Burstein, Harold J., Carey, Lisa A., Overmoyer, Beth, Cirrincione, Constance T., Sikov, William M., Golshan, Mehra, Henry, Nora L., for the Alliance for Clinical Trials in Oncology, Hudis, Clifford, Winer, Eric, Ollila, David W., Port, Elisa, Berry, Donald A., Somlo, George
It had been previously shown that patients who receive neoadjuvant systemic therapy (NST) are more likely to undergo breast-conserving therapy (BCT) than those who have primary surgery. However, the frequency with which patients who are not BCT-eligi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e368a0497b33f7f70313d09e2127d554
Autor:
Kim, Hyung L, Halabi, Susan, Li, Ping, Mayhew, Greg, Simko, Jeff, Nixon, Andrew B, Small, Eric J, Rini, Brian, Morris, Michael J, Taplin, Mary-Ellen, George, Daniel, Alliance for Clinical Trials in Oncology
Publikováno v:
EBioMedicine, vol 2, iss 11
BackgroundPrognosis associated with metastatic renal cell carcinoma (mRCC) can vary widely.MethodsThis study used pretreatment nephrectomy specimens from a randomized phase III trial. Expression levels of candidate genes were determined from archival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::433cd175e5b55596b69f7a3e9e27d8ce
https://escholarship.org/uc/item/1gb062g3
https://escholarship.org/uc/item/1gb062g3
Autor:
Shiovitz, Stacey, Bertagnolli, Monica M, Renfro, Lindsay A, Nam, Eunmi, Foster, Nathan R, Dzieciatkowski, Slavomir, Luo, Yanxin, Lao, Victoria Valinluck, Monnat, Raymond J, Emond, Mary J, Maizels, Nancy, Niedzwiecki, Donna, Goldberg, Richard M, Saltz, Leonard B, Venook, Alan, Warren, Robert S, Grady, William M, Alliance for Clinical Trials in Oncology
Publikováno v:
Gastroenterology, vol 147, iss 3
Background & aimsThe CpG island methylator phenotype (CIMP), defined by a high frequency of aberrantly methylated genes, is a characteristic of a subclass of colon tumors with distinct clinical and molecular features. Cohort studies have produced con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::7ac55cd841609ce7dda1449b1397c295
https://escholarship.org/uc/item/66873004
https://escholarship.org/uc/item/66873004
Autor:
Van Loon, Katherine, Owzar, Kouros, Jiang, Chen, Kindler, Hedy L, Mulcahy, Mary F, Niedzwiecki, Donna, O'Reilly, Eileen M, Fuchs, Charles, Innocenti, Federico, Venook, Alan P, Alliance for Clinical Trials in Oncology
Publikováno v:
Journal of the National Cancer Institute, vol 106, iss 8
BackgroundData from animal and cell-line models suggest that vitamin D metabolism plays an important role in pancreatic tumor behavior. Although vitamin D deficiency has been implicated in numerous cancers, the vitamin D status of patients with advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::bbb817c7985bb5adc7e06bdc88f28cdc
https://escholarship.org/uc/item/8s33r36c
https://escholarship.org/uc/item/8s33r36c
Autor:
Nixon, Andrew B, Pang, Herbert, Starr, Mark D, Friedman, Paula N, Bertagnolli, Monica M, Kindler, Hedy L, Goldberg, Richard M, Venook, Alan P, Hurwitz, Herbert I, Alliance for Clinical Trials In Oncology
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 19, iss 24
PurposeCALGB80303 was a phase III trial of 602 patients with locally advanced or metastatic pancreatic cancer comparing gemcitabine/bevacizumab versus gemcitabine/placebo. The study found no benefit in any outcome from the addition of bevacizumab to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::5101d13b9c3ee9dba71fc6a3bba3a9a2
https://escholarship.org/uc/item/7249d5rg
https://escholarship.org/uc/item/7249d5rg
Autor:
Aggarwal, Rahul, Halabi, Susan, Kelly, William Kevin, George, Daniel, Mahoney, John F, Millard, Frederick, Stadler, Walter M, Morris, Michael J, Kantoff, Philip, Monk, J Paul, Carducci, Michael, Small, Eric J, Alliance for Clinical Trials in Oncology
Publikováno v:
Cancer, vol 119, iss 20
BackgroundPreliminary data suggest a potential decreased benefit of docetaxel in patients with metastatic, castration-resistant prostate cancer (mCRPC) who previously received abiraterone acetate, a novel androgen synthesis inhibitor (ASI). Cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::af0fe86e457be39148c2f3d5cf9a6e82
https://escholarship.org/uc/item/28d6p66f
https://escholarship.org/uc/item/28d6p66f
Autor:
Lewis, Lionel D, Miller, Antonius A, Owzar, Kouros, Bies, Robert R, Markova, Svetlana, Jiang, Chen, Kroetz, Deanna L, Egorin, Merrill J, McLeod, Howard L, Ratain, Mark J, Alliance for Clinical Trials in Oncology
Publikováno v:
Pharmacogenetics and genomics, vol 23, iss 1
Docetaxel-related neutropenia was associated with polymorphisms in the drug transporters ABCC2 and SLCO1B3 in Japanese cancer patients. We hypothesized that this association is because of reduced docetaxel clearance, associated with polymorphisms in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bdc914237093c8aa4a9846633b25d6c2
https://escholarship.org/uc/item/3th2673d
https://escholarship.org/uc/item/3th2673d
Autor:
Snyder, Rebecca A., Hu, Chung-Yuan, Cuddy, Amanda, Francescatti, Amanda B., Schumacher, Jessica R., Van Loon, Katherine, You, Y. Nancy, Kozower, Benjamin D., Greenberg, Caprice C., Schrag, Deborah, Venook, Alan, McKellar, Daniel, Winchester, David P., Chang, George J., Alliance for Clinical Trials in Oncology Network Cancer Surveillance Optimization Working Group
Publikováno v:
JAMA: Journal of the American Medical Association; 5/22/2018, Vol. 319 Issue 20, p2104-2115, 12p